Aceragen, Inc.

Withdrawn

Formerly IDERA PHARMACEUTICALS, INC.

MergerMerger / acquisition — shareholder vote (DEFM14A)

The Form 10 registration was withdrawn on July 10, 2018 — this spin-off did not complete as filed (the company was sold, merged, or the plan was abandoned).

Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Exchange: —
State of incorporation: DE
Form: DEFM14A
Filed: May 30, 2018

Deal approval & antitrust

merger-arb risk

A change of control closes only once its regulators clear it. These agencies have jurisdiction given the company's sector — track each one's docket for this deal. We link the official source; we do not assert an outcome.

FTC ↗Antitrust / competition review (Hart-Scott-Rodino)DOJ Antitrust Division ↗Antitrust / competition review (Hart-Scott-Rodino)

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.

Source filing ↗DEFM14A · the filing we parse All documents in this filing ↗accession 0001047469-18-004164 Aceragen, Inc. — all SEC filings ↗EDGAR company page

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.